Drawing for ATLAS

USPTO serial 99401036

ATLAS

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
SHEN, ELIZABETH S
Law office
TMO LAW OFFICE 132

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ATLAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel H. Landau

Daniel H. Landau Hayes Soloway P.C.4640 E Skyline DrTucson, AZ 85718United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Downloadable computer software using artificial intelligence (AI) for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Downloadable cloud-computing software for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; all excluding the fields of individual patient medical information, records, care, treatment, testing, monitoring, sample collection; all excluding laboratory use, all excluding the fields of bioinformatics, pharmaceuticals, and genetic data analysis, testing, sampling, and monitoringACTIVE—
035Business administration services in the field of population-level healthcareACTIVE—
042Platform as a service (PAAS) featuring computer software platforms for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Cloud computing featuring software for use with value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Software as a service (SAAS) services featuring software for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Providing on-line non-downloadable software using artificial intelligence (AI) for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare, all excluding the fields of individual patient medical information, records, care, treatment, testing, monitoring, sample collection; all excluding laboratory use; all excluding the fields of bioinformatics, pharmaceuticals, and genetic data analysis, testing, sampling, and monitoringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 9, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 9, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 9, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Feb 9, 2026CNSLSUSPENSION LETTER WRITTEN—
Jan 6, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 6, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2025DOCKASSIGNED TO EXAMINER—
Sep 18, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 18, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 18, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance